Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2000
06/13/2000US6075039 5HT receptor binding benzimidazolylpiperidines
06/13/2000US6075034 Spiro[piperidine-4,1'-pyrrolo [3,4-C] pyrrole]derivatives
06/13/2000US6075026 Certain substituted 1-aryl-3-piperazin-1'-yl propanones
06/13/2000US6075021 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and application thereof in therapeutics
06/13/2000US6075018 Tranquilizers
06/13/2000US6075006 For treatment of arthritis, asthma, inflammation, tumoral growth, gastro intestinal hypermotility, huntington disease, neuritis, neuralgia, migraine, hypertension, incontinence of urine, urticaria, symptoms of the carcinoid syndrome
06/13/2000US6074839 Transforming growth factor αHI
06/13/2000CA2107014C Therapeutic agent for parkinson's disease
06/13/2000CA1341025C Substituted silyl alkylene amines
06/13/2000CA1341024C Benzo-fused cycloalkane and oxa- and thia-, cycloalkane trans-1, 2-diamine derivatives
06/08/2000WO2000032805A1 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
06/08/2000WO2000032766A1 Human vanilloid receptors and their uses
06/08/2000WO2000032751A2 Mammalian non-neuronal cells that are modified to store and release a neurotransmitter
06/08/2000WO2000032633A1 Novel adhesion molecule and methods of use
06/08/2000WO2000032627A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000WO2000032624A2 Uncoupling protein 5 - ucp5
06/08/2000WO2000032620A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
06/08/2000WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/08/2000WO2000032597A1 Process for the production of paroxetine hydrochloride propan-2-ol solvate
06/08/2000WO2000032595A1 Process for the production of paroxetine hydrochloride acetone solvate
06/08/2000WO2000032594A1 Mixed paroxetine propan-2-ol solvates
06/08/2000WO2000032593A1 Method of producing paroxetine hydrochloride
06/08/2000WO2000032592A1 Process for the preparation of paroxetine hydrochloride
06/08/2000WO2000032589A1 Eletriptan hydrobromide monohydrate
06/08/2000WO2000032584A2 Nonsteroidal antiinflammatories
06/08/2000WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors
06/08/2000WO2000032567A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
06/08/2000WO2000032558A1 Therapeutic product and its use
06/08/2000WO2000032557A1 Novel 3-alkoxybenzylamine derivatives and their use as medicines for treating schizophrenia
06/08/2000WO2000032556A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same
06/08/2000WO2000032555A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same
06/08/2000WO2000032551A1 Sertraline hydrochloride polymorphs
06/08/2000WO2000032239A1 Hapten-carrier conjugates for treating and preventing nicotine addiction
06/08/2000WO2000032236A1 Peptides carrying substances across the blood brain barrier
06/08/2000WO2000032232A1 Agent containing an additional local anaesthetic for the treatment of symptoms of parkinson's disease
06/08/2000WO2000032216A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
06/08/2000WO2000032198A1 Use of selected modulators of p2 purinoceptors for the prevention of damage and mortality caused by global cerebral ischemia and ischemia-reperfusion
06/08/2000WO2000032197A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
06/08/2000WO2000032190A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases
06/08/2000WO2000032189A1 Celecoxib compositions
06/08/2000WO2000032187A1 A new pharmaceutical composition
06/08/2000WO2000032185A1 Use of effectors of the central cholinergic nervous system
06/08/2000WO2000032183A1 Topiramate and related derivatives for treating schizophrenia
06/08/2000WO2000032178A2 Use of siburamine for the treatment of disorders of the central nervous system secondary to organic impairments
06/08/2000WO2000032175A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
06/08/2000WO2000032171A2 Autoahesive oral transmucosal delivery dosage form
06/08/2000WO2000015245A3 Stable liquid formulations of botulinum toxin
06/08/2000WO2000012505A3 Triazolopyridazine derivatives for treating anxiety and enhancing cognition
06/08/2000WO2000012481A3 Indazole derivatives with 5-ht2 receptor activity________________
06/08/2000WO2000009103A9 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders
06/08/2000WO1999024076A9 Salicylate derivatized therapeutic and diagnostic agents
06/08/2000DE19856052A1 Konjugat zur Anreicherung in neuronalen Zellen Conjugate to accumulate in neuronal cells
06/08/2000CA2354158A1 Novel 3-alkoxybenzylamine derivatives and their use as medicines for treating schizophrenia
06/08/2000CA2353795A1 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
06/08/2000CA2353402A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
06/08/2000CA2353079A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
06/08/2000CA2352789A1 Use of selected modulators of p2 purinoceptors for the prevention of damage and mortality caused by global cerebral ischemia and ischemia-reperfusion
06/08/2000CA2352760A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000CA2352491A1 Peptides carrying substances across the blood brain barrier
06/08/2000CA2352367A1 Nonsteroidal antiinflammatories
06/08/2000CA2352321A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same
06/08/2000CA2350635A1 Therapeutic product and its use
06/08/2000CA2350597A1 Methods and compositions for restoring conformational stability of a protein of the p53 family
06/08/2000CA2349402A1 A new pharmaceutical composition
06/08/2000CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/08/2000CA2319646A1 Topiramate and related derivatives for treating schizophrenia
06/07/2000EP1006112A1 3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers
06/07/2000EP1006110A1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
06/07/2000EP1006108A1 3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers
06/07/2000EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions
06/07/2000EP1005863A1 Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
06/07/2000EP1005550A1 Ubc7-like ubiquitin-conjugating enzyme
06/07/2000EP1005471A1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action
06/07/2000EP1005463A1 Furansulfonic acid derivatives and pharmaceutical compositions containing the same
06/07/2000EP1005459A1 Substituted isoquinolines as anticonvulsivants
06/07/2000EP1005445A1 N-alkanoylphenylalanine derivatives
06/07/2000EP1005372A1 Anti-cd40l immunotoxins for the treatment of diseases
06/07/2000EP1005348A1 Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
06/07/2000EP1005341A1 Il-8 receptor antagonists
06/07/2000EP1005334A1 Neuroprotective compounds and uses thereof
06/07/2000EP0727994B1 Antipyretic and analgesic methods and compositions containing optically pure r-etodolac
06/07/2000EP0699197B1 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia
06/07/2000CN1255917A Anti-convulsant isoquinolyl-benzamide derivatives
06/07/2000CN1255852A Novel method and compsns. for drug feeding of taxad alkyl compounds
06/07/2000CN1255493A Novel dihydro and tetrahydro chinoline compounds, its prepn. method and medicinal compsns.
06/07/2000CN1255374A Medicine for curing diseases in nerve system and its preparing process
06/07/2000CN1255370A Chinese-medicinal analgesic and sedative and preparing process thereof
06/07/2000CN1255337A Medicine for treating hydrocephalus
06/07/2000CN1053190C Quinoxalindione derivs, their prepn. and their used in drugs
06/07/2000CN1053189C Pyridazino qujinoline compounds
06/07/2000CN1053187C Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
06/06/2000US6072068 Treating glucocorticoid-dependent diseases or symptoms
06/06/2000US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections
06/06/2000US6071970 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/06/2000US6071969 Substituted aminoguanidines and methods of use thereof
06/06/2000US6071968 Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant
06/06/2000US6071932 Carbazolypiperines as GABA uptake inhibitors
06/06/2000US6071929 Selective blockers of n-methyl-d-aspartic acid for teatment of nervous system and brain disorders or injuries
06/06/2000US6071927 Tachykinnin antagonists for the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
06/06/2000US6071925 Antidepressants, anticonvulsants or antianxiety agents, also for treatment of memory loss in alzheimer's disease
1 ... 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 ... 1833